mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has been rising in incidence primarily related to HPV‐associated oropharyngeal cancers. Novel molecular therapeutics are evolving with the mTOR pathway as a new target. Previous studies have shown variable outcomes with relatively low toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jaimin, Nguyen, Shaun A., Ogretmen, Besim, Gutkind, Jorge S., Nathan, Cherie‐Ann, Day, Terry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Head and Neck, and Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178455/
https://www.ncbi.nlm.nih.gov/pubmed/32337356
http://dx.doi.org/10.1002/lio2.370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178455/
https://www.ncbi.nlm.nih.gov/pubmed/32337356
http://dx.doi.org/10.1002/lio2.370

Ejemplares similares